CLINICAL RESEARCH FOR PEDIATRIC ALOPECIA AREATA: ORAL

Alopecia Areata is estimated to affect 6.8 million Americans and can affect  men, women and children of all ages. Pediatric alopecia affects about 1 in 1,000 children and teens. 

We are currently conducting a clinical research study testing an investigational oral medication in pediatric patients with alopecia areata. We are looking for participants who meet the following criteria:

• Ages 12-17
• 50% or more hair loss
• 1 year clinical diagnosis of Alopecia Areata 

*Other qualifications will be checked during a screening visit with a board-certified provider. *

*Even if you do not qualify you will receive a consultation & recommendations for treatment at no charge by a board-certified provider!* 

Study Duration: Approximately 8 months